Chlamydia pneumoniae IgG Control Serum BC1371G

$94.00

Summary

Virion/Serion Diagnostic Kit Control for research use (RUO)
Chlamydia pneumoniae IgG Control Serum
Applications: ELISA
IgA control serum
Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
3 mL

SKU: BC1371G Categories: control serum, Virion/Serion kits Tags: Chlamydia, ELISA control serum, IgG

Weight	1 lbs
Dimensions	9 × 5 × 2 in
target	Chlamydia pneumoniae reactive IgG
species reactivity	Chlamydia pneumoniae
applications	ELISA
assay type	Indirect & quantitative
available size	3 mL

Chlamydia pneumoniae IgG Control Serum BC1371G

kit
Research area Infectious Disease
Storage Store at 2-8°C.
Associated products Chlamydia trachomatis EB + RB Antigen (BA1372VSER) Chlamydia trachomatis MOMP Antigen (BA1372VSR2) Chlamydia trachomatis IgA Control Serum (BC1372A) Chlamydia trachomatis IgG Control Serum (BC1372G) Chlamydia trachomatis IgM Control Serum (BC1372M) Chlamydia trachomatis IgA ELISA Kit (ESR1372A) Chlamydia trachomatis IgG ELISA Kit (ESR1372G) Chlamydia trachomatis IgM ELISA Kit (ESR1372M) Chlamydia IgA ELISA Kit (ESR137A)

target relevance

human antibody anti-Chlamydia pneumoniae

Chlamydia pneumoniae

Description
Bacterium that causes respiratory tract infections and atypical pneumonia

Structure
Chlamydia pneumoniae is an obligate intracellular Gram-negative bacterium belonging to the family Chlamydiaceae. Like other Chlamydia species, it possesses a unique biphasic developmental cycle consisting of an infectious elementary body (EB) and a metabolically active reticulate body (RB). Elementary bodies are responsible for transmission and host cell invasion, whereas reticulate bodies replicate within membrane-bound intracellular inclusions. Chlamydia pneumoniae is a strictly human pathogen and is transmitted primarily through respiratory droplets. The organism infects epithelial cells and macrophages within the respiratory tract and is a common cause of community-acquired respiratory infections worldwide. Chronic or persistent infection has also been investigated for possible associations with atherosclerosis, asthma, and other chronic inflammatory conditions, although these relationships remain incompletely understood.

Diagnosis
The diagnosis of Chlamydia pneumoniae infection is performed through molecular, serological, and microbiological methods. Polymerase chain reaction (PCR) assays are considered the most sensitive and specific diagnostic tools and allow direct detection of bacterial DNA in respiratory specimens. Serological testing using ELISA, microimmunofluorescence (MIF), or complement fixation assays may be used to detect Chlamydia pneumoniae-specific antibodies and assess recent or past infection. Culture is technically demanding because the organism is an obligate intracellular pathogen and is rarely performed outside specialized laboratories. Diagnosis often relies on a combination of clinical presentation, imaging findings, and laboratory testing due to the nonspecific nature of symptoms.

Symptoms
Chlamydia pneumoniae infection typically develops following an incubation period of approximately three to four weeks. The disease commonly presents as a mild upper respiratory tract infection characterized by sore throat, hoarseness, runny nose, headache, fatigue, and low-grade fever. Infection may progress to bronchitis or atypical pneumonia, resulting in persistent dry cough, chest discomfort, shortness of breath, and malaise. Symptoms often develop gradually and may persist for several weeks. While most infections are self-limiting, severe disease can occur in elderly individuals, immunocompromised patients, and those with underlying cardiopulmonary disorders. Reinfections are common throughout life due to incomplete protective immunity.

Data

FAQ & Publications

Frequently Asked Questions

What is the primary application of the Chlamydia pneumoniae IgG Control Serum BC1371G?

The Chlamydia pneumoniae IgG Control Serum BC1371G is primarily used as a control serum for ELISA assays, specifically designed for indirect and quantitative detection of Chlamydia pneumoniae reactive IgG antibodies.

How should the Chlamydia pneumoniae IgG Control Serum BC1371G be stored to maintain its stability?

This control serum should be stored at 2-8°C to preserve its stability and usability for research purposes.

Is the Chlamydia pneumoniae IgG Control Serum BC1371G ready to use or does it require dilution?

The serum is supplied ready-to-use and pre-diluted specifically for use with SERION ELISA classic and SERION ELISA antigen assays.

What species reactivity does the Chlamydia pneumoniae IgG Control Serum BC1371G exhibit?

The serum exhibits species reactivity specifically to Chlamydia pneumoniae, targeting its reactive IgG antibodies.

Can the Chlamydia pneumoniae IgG Control Serum BC1371G be used with indirect ELISA assay formats?

Yes, this control serum is validated for use in indirect and quantitative ELISA assay formats for research use.

Publications

pmid	title	authors	citation
We haven't added any publications to our database yet.

Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from the PubMed database provided by the United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BC1371G protocol

Documents

#
Please enter your product and batch number here.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Chlamydia pneumoniae IgG Control Serum BC1371G

Data

FAQ & Publications

Protocols

Documents

Related Technical Resources & Posts

Reviews

Related Products

Borrelia burgdorferi IgG Control Serum BC121G

Echovirus IgG Control Serum BC135G

Bordetella pertussis IgG Control Serum BC120G

Coxsackie IgG Virus Control Serum BC134G

Aspergillus fumigatus IgG Control Serum BC132G

Chlamydia trachomatis IgA Control Serum BC1372A

Adenovirus IgG Control Serum BC128G

Chlamydia trachomatis IgG Control Serum BC1372G

Human Chlamydia IgG Lateral flow dipstick kit 6172

Chlamydia trachomatis IgM Control Serum BC1372M

Chlamydia pneumoniae IgA Control Serum BC1371A

Chlamydia pneumoniae IgM Control Serum BC1371M

Candida albicans IgG Control Serum BC117G

Campylobacter jejuni IgG Control Serum BC139G

Brucella IgG Control Serum BC116G